Royal Pharmaceutical Society

rpharms.com

The Royal Pharmaceutical Society is the professional body for pharmacists and pharmacy, representing over 46,000 pharmacists, pharmacy students, trainees and pharmaceutical scientists across Great Britain and enhancing the reputation of pharmacy worldwide.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

IMPLEMENTING THE COMMUNITY PHARMACY FORWARD VIEW

Royal Pharmaceutical Society | January 19, 2017

news image

Pharmacy Voice and PSNC, with the support of the RPS, have today launched the next phase of the Community Pharmacy Forward View (CPFV) project, with a new website and report outlining an implementation framework for delivering the CPFV vision....

Read More

PARTNERSHIP WITH PHARMACY MANAGEMENT TO SUPPORT MEMBERS PROFESSIONAL DEVELOPMENT

Royal Pharmaceutical Society | January 20, 2017

news image

We are pleased to announce that we have formed a new partnership with Pharmacy Management, who will support our ongoing professional development provided to our members. Pharmacy Management is a specialist pharmacy communications company, which publishes professional journals and runs conferences and training programmes across the UK. It is a RPS Faculty Accredited training provider....

Read More

GROUND-BREAKING COLLABORATION TO OFFER NEW HEART DISEASE DRUG TO NHS PATIENTS

Pharmacy Business | January 14, 2020

news image

The government on Monday announced a collaboration with Novartis to launch a clinical trial for ‘yet to be approved’ drug inclisiran. The drug could benefit thousands of patients at risk of heart disease in coming years. The ground-breaking collaboration includes Novartis, NHS England and the National Institute for Health Research (NIHR) and Oxford University. The Department of Health and Social Care (DHSC) expects this to position the UK as a world-leading destination to develop cut...

Read More

CIVICA RX PARTNERS WITH THERMO FISHER SCIENTIFIC TO DEVELOP AND MANUFACTURE DRUGS WITH A HISTORY OF DRUG SHORTAGES

Business Wire Press Releases | January 16, 2020

news image

Today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will secure the manufacture of certain essential medications, further mitigating the risk of drug shortages in the future. This partnership has an initial seven-year term and represents a key component of Civica’s man...

Read More
news image

IMPLEMENTING THE COMMUNITY PHARMACY FORWARD VIEW

Royal Pharmaceutical Society | January 19, 2017

Pharmacy Voice and PSNC, with the support of the RPS, have today launched the next phase of the Community Pharmacy Forward View (CPFV) project, with a new website and report outlining an implementation framework for delivering the CPFV vision....

Read More
news image

PARTNERSHIP WITH PHARMACY MANAGEMENT TO SUPPORT MEMBERS PROFESSIONAL DEVELOPMENT

Royal Pharmaceutical Society | January 20, 2017

We are pleased to announce that we have formed a new partnership with Pharmacy Management, who will support our ongoing professional development provided to our members. Pharmacy Management is a specialist pharmacy communications company, which publishes professional journals and runs conferences and training programmes across the UK. It is a RPS Faculty Accredited training provider....

Read More
news image

GROUND-BREAKING COLLABORATION TO OFFER NEW HEART DISEASE DRUG TO NHS PATIENTS

Pharmacy Business | January 14, 2020

The government on Monday announced a collaboration with Novartis to launch a clinical trial for ‘yet to be approved’ drug inclisiran. The drug could benefit thousands of patients at risk of heart disease in coming years. The ground-breaking collaboration includes Novartis, NHS England and the National Institute for Health Research (NIHR) and Oxford University. The Department of Health and Social Care (DHSC) expects this to position the UK as a world-leading destination to develop cut...

Read More
news image

CIVICA RX PARTNERS WITH THERMO FISHER SCIENTIFIC TO DEVELOP AND MANUFACTURE DRUGS WITH A HISTORY OF DRUG SHORTAGES

Business Wire Press Releases | January 16, 2020

Today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will secure the manufacture of certain essential medications, further mitigating the risk of drug shortages in the future. This partnership has an initial seven-year term and represents a key component of Civica’s man...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us